Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
), Faculty of Medicine, University of Southampton (UoS). The group is studying the Preclinical efficacy and safety of ADAM33 oligonucleotides as new disease-modifying asthma therapy in pre-clinical murine and
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 18 hours ago
focused on the classification and characterization of human and animal models tumors through the study of gene expression patterns, tumor DNA copy number changes, and DNA somatic mutations identified using
-
of €4010/month (correction factor to be applied per country, and local employer’s contributions) Your Tasks RF7: Personalization, adequate monitoring and guidance of micronutrient therapy in cardiac
-
an emphasis on ensuring patient safety. Overseeing compounding of complex therapies, including gene therapy and first in human trials, utilizing a variety of unique methods of delivery. Providing expertise
-
(CCRM) for the Department of Neurological Surgery Human Gene Therapy Clinical Research Team; assists with assessing patient records to identify patients who are eligible to participate in specified
-
(TRANS-AM) Gene therapies are a type of advanced medicine that represent exciting possibilities to treat and potentially cure many life-altering and life-threatening diseases. They also represent a huge
-
peptide, mRNA, or gene therapy development related to mitochondrial disease. Computational biology / bioinformatics, especially ribosome profiling, disease gene discovery, or integrative multi‑omic
-
), Faculty of Medicine, University of Southampton (UoS). The group is studying the Preclinical efficacy and safety of ADAM33 oligonucleotides as new disease-modifying asthma therapy in pre-clinical murine and
-
of Masaryk University in Brno was established on 1 January 2024 and focuses on research and development of cell and gene therapy for selected rare diseases. The CZECRIN Large Research Infrastructure (LRI) is
-
DNA damaging therapies have been successful in treating cancer patients for decades. The standard of care therapy for many cancers include small molecule inhibitors, however these therapies have